Trial · NCT04622709
Adverse events12
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 12 of 12
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Inner EAR hearing assessment score decreased by >10 points from baseline | Ear and labyrinth disorders | Study Drug Administration: Furosemide | 3 | 39 | 4 |
| other | Hypotension during dialysis treatment | Renal and urinary disorders | Study Drug Administration: Furosemide | 2 | 39 | 2 |
| other | Severe tinnitus | Ear and labyrinth disorders | Study Drug Administration: Furosemide | 1 | 39 | 9 |
| serious | Hospitalization for stroke | Nervous system disorders | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for cardiogenic shock | Cardiac disorders | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for clostridium difficile infection | Infections and infestations | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for COVID-19 infection | Infections and infestations | Study Drug Administration: Furosemide | 2 | 39 | 2 |
| serious | Death due to COVID-19-related respiratory failure | Infections and infestations | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for acute respiratory failure due to volume overload | Respiratory, thoracic and mediastinal disorders | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for non-ST-elevation myocardial infarction | Cardiac disorders | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for toe osteomyelitis requiring amputation | Surgical and medical procedures | Study Drug Administration: Furosemide | 1 | 39 | 1 |
| serious | Hospitalization for perforated ulcer, resulting in patient death | Gastrointestinal disorders | Study Drug Administration: Furosemide | 1 | 39 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04622709/events